Detalles de la búsqueda
1.
Applying the Milan models to setting analytical performance specifications - considering all the information.
Clin Chem Lab Med
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801089
2.
Outcome-based analytical performance specifications: current status and future challenges.
Clin Chem Lab Med
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38836433
3.
The validity of progression-free survival 2 as a surrogate trial end point for overall survival.
Cancer
; 128(7): 1449-1457, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985773
4.
Benchmarking single-arm studies against historical controls from non-small cell lung cancer trials - an empirical analysis of bias.
Acta Oncol
; 59(1): 90-95, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31608733
5.
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
Circulation
; 137(4): 354-363, 2018 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138293
6.
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.
Breast Cancer Res Treat
; 174(1): 271-278, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30465154
7.
False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
Ann Surg Oncol
; 26(6): 1860-1868, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30911946
8.
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer.
Future Oncol
; 15(20): 2371-2383, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31354046
9.
Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice.
Ann Emerg Med
; 68(1): 93-102.e1, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26947800
10.
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials.
JCO Precis Oncol
; 8: e2300296, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38207226
11.
Patient-centred outcomes of imaging tests: recommendations for patients, clinicians and researchers.
BMJ Qual Saf
; 32(9): 536-545, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34615733
12.
Reduced number of admissions with acute appendicitis but not severe acute appendicitis at two Sydney hospitals during the first COVID-19 lockdown period.
ANZ J Surg
; 92(7-8): 1737-1741, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635054
13.
Simulations found within-subject measurement variation in glycaemic measures may cause overdiagnosis of prediabetes and diabetes.
J Clin Epidemiol
; 145: 20-28, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965479
14.
Incorporating circulating tumor DNA detection to radiographic assessment for treatment response in advanced EGFR-mutant lung cancer.
Lung Cancer
; 163: 14-18, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894454
15.
How often are patients with clinically apparent inguinal hernias referred to a surgeon accompanied with an ultrasound? A prospective multicentre study.
Aust Health Rev
; 45(1): 36-41, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854817
16.
Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-Analysis.
JCO Precis Oncol
; 52021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296055
17.
Impact of ultrasound on inguinal hernia repair rates in Australia: a population-based analysis.
ANZ J Surg
; 91(7-8): 1604-1609, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870618
18.
Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios.
Prostate Cancer Prostatic Dis
; 24(3): 662-673, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33654249
19.
Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis.
Lung Cancer
; 154: 113-117, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33647577
20.
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 3(9): e2011809, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897371